Transforming Women's Health.

Dedicated to improving the lives of women, starting with Ovarian Cancer

Latest News & Events

View More

  • Aspira Women’s Health Reports First Quarter 2021 Financial Results

    Press Release

    Read More
  • Aspira Women’s Health to Reveal 3rd Generation Ovarian Cancer Risk Assessment Technology at ASCO 2021

    Press Release

    Read More
  • Aspira Women’s Health Initiates Prospective Clinical Study for Benign Risk Monitoring and High Risk Early Ovarian Cancer Detection with Northwell Health®

    Press Release

    Read More

The Ovarian Cancer story has to change, Aspira is passionately dedicated to making a difference.

We are committed to solving women's health issues for all ethnicities, stages, and ages. Our data-driven approach delivers solutions that help women take control of their gynecologic health and empowers providers to deliver optimal care. We are using our 10+ years of experience in ovarian cancer risk assessment to develop a cutting-edge portfolio of pelvic mass products.

Learn About Our Research

Our Products


  • Relentless pursuit of products to improve ovarian cancer detection and care. Learn about why OVA1plus is the best way to assess risk prior to surgery.

    Learn More
  • Hereditary Gynecologic cancer detection and carrier screening. Learn about your inherited risk through genetic testing.

    Learn More
  • Aspira Synergy is a technology transfer platform that enables our customers to bring in-house the ability to perform specialty testing. Learn more about how to bring both OVA1plus and state-of-the-art genetic testing into your laboratory.

    Learn More

Testimonials


  • OVA1 is using five different biomarkers compared to other tests, and is much more sensitive especially for detection of early stage disease.

    - Kathy Anderson MD, FACOG, JD, ABAARM
  • OVA1 is great in that it can help to avoid second procedures on patients and second operations which can be associated with higher morbidity.

    - Jonathan Black MD, MPH
  • OVA1®plus has added to our armamentarium as physicians by decreasing the false positive rate up to 50%

    - Howard C. Mandel MD, FACOG

Careers At Aspira Women's Health

Aspira is dedicated to transforming women's health with a unique approach to ovarian cancer risk assessment and detection.


We are always looking for talented, driven individuals to join our team of innovators. We are a small company with some very big ideas.

Are you ready to help us inspire change in women's health? Then we want to hear from you!

Join Us!